Skip to main content
Ilaris 150 mg/mL injection, solution by Novartis Pharmaceuticals Corporation
Ilaris, 150 mg/mL, injection, solution Available on prescription only. Listed by Novartis Pharmaceuticals Corporation.
Prescription only

Ilaris

canakinumab

Listed by Novartis Pharmaceuticals Corporation

Strength
150 mg/mL
Form
Injection, Solution
Route
Subcutaneous

What it contains

  • Canakinumab 150 mg/mL

FDA record

Dosage form Injection, Solution
Route Subcutaneous
Approval route BLA — biologic licence
NDC code 0078-0734
FDA application BLA125319
RxNorm concept 1864324
Package sizes listed 1
Marketed since December 2016

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.